Gf Fund Management Co. Ltd. Spring Works Therapeutics, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $4.62 Trillion
- Q4 2024
A detailed history of Gf Fund Management Co. Ltd. transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 1,562 shares of SWTX stock, worth $90,986. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,562Holding current value
$90,986% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SWTX
# of Institutions
236Shares Held
67.2MCall Options Held
260KPut Options Held
316K-
Vanguard Group Inc Valley Forge, PA7.16MShares$417 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$327 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.46MShares$202 Million5.51% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.27MShares$191 Million0.01% of portfolio
-
State Street Corp Boston, MA3MShares$175 Million0.0% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $3.63B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...